Combination chemotherapy with temozolomide, lomustine, vincristine and interferon-alpha (TOL-IFN) plus vemurafenib or TOL-IFN as first-line treatment for patients with advanced melanoma

Kalle E. Mattila, Pia Vihinen, Susan Ramadan, Tanja Skyttä, Leena Tiainen, Meri-Sisko Vuoristo, Kristiina Tyynelä-Korhonen, Jussi Koivunen, Laura Kohtamäki, S Mäkelä, Siru Makela, Micaela Hernberg

Research output: Contribution to journalArticleScientific

3 Citations (Scopus)
Original languageEnglish
Pages (from-to)310-314
JournalActa Oncologica
Volume59
Issue number3
DOIs
Publication statusPublished - 2019
Publication typeB1 Journal article

Cite this